Damon Disch

Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

Silvana Martino, Jane A. Cauley, Elizabeth Barrett‐Connor et al. · JNCI Journal of the National Cancer Institute · 2004 · 683 citations · Full text

A randomized phase 2b trial of baricitinib, an oral Janus kinase (<scp>JAK</scp>) 1/JAK2 inhibitor, in patients with moderate‐to‐severe psoriasis

Kim Papp, Alan Menter, Maitreyi Raman et al. · British Journal of Dermatology · 2016 · 251 citations · Full text

Safety assessment of raloxifene over eight years in a clinical trial setting

Silvana Martino, Damon Disch, Sherie A. Dowsett et al. · Current Medical Research and Opinion · 2005 · 112 citations

Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies

Bente Langdahl, Stuart L. Silverman, Saeko Fujiwara et al. · Bone · 2018 · 101 citations · Full text

Bone Disease, Skeletal Trauma, Fracture Reduction +9

Teriparatide in patients with osteoporosis and type 2 diabetes

Ann V. Schwartz, Imre Pávó, Jahangir Alam et al. · Bone · 2016 · 93 citations

Metabolic Syndrome, Bone Health, Diabetes +5